Symbols / PROF Stock $6.54 -4.80% Profound Medical Corp.

Healthcare • Medical Devices • Canada • NCM
PROF (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Dr. Arun Swarup Menawat MBA, Ph.D.
Exch · Country NCM · Canada
Market Cap 237.65M
Enterprise Value 206.81M
Income -38.90M
Sales 18.81M
FCF (ttm) -22.77M
Book/sh 1.64
Cash/sh 1.38
Employees 162
Insider 10d —
IPO Oct 29, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -8.70
PEG —
P/S 12.63
P/B 4.00
P/C —
EV/EBITDA -5.50
EV/Sales 10.99
Quick Ratio 5.63
Current Ratio 6.55
Debt/Eq 12.56
LT Debt/Eq —
EPS (ttm) -1.24
EPS next Y -0.75
EPS Growth —
Revenue Growth 103.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-05-07
ROA -35.47%
ROE -70.59%
ROIC —
Gross Margin 71.08%
Oper. Margin -150.29%
Profit Margin -206.76%
Shs Outstand 36.34M
Shs Float 34.74M
Insider Own 4.07%
Instit Own 47.96%
Short Float 6.87%
Short Ratio 31.17
Short Interest 2.20M
52W High 8.95
vs 52W High -26.93%
52W Low 3.76
vs 52W Low 73.94%
Beta 0.52
Impl. Vol. 0.66%
Rel Volume 0.68
Avg Volume 112.58K
Volume 76.80K
Target (mean) $11.14
Tgt Median $11.20
Tgt Low $10.00
Tgt High $12.00
# Analysts 5
Recom None
Prev Close $6.87
Price $6.54
Change -4.80%
About

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$11.14
Mean price target
2. Current target
$6.54
Latest analyst target
3. DCF / Fair value
$-11.28
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.54
Low
$10.00
High
$12.00
Mean
$11.14

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-07 main Lake Street Buy → Buy $12
2025-04-23 main Lake Street Buy → Buy $11
2024-07-16 up Stifel Hold → Buy $12
2024-03-11 main Alliance Global Partners Buy → Buy $11
2024-03-08 main Stifel Hold → Hold $9
2024-01-04 main Alliance Global Partners Buy → Buy $13
2023-11-28 init Stifel — → Hold $11
2023-08-04 down Raymond James Strong Buy → Outperform —
2023-05-11 main TD Cowen — → Outperform $18
2023-05-11 main Alliance Global Partners — → Buy $16
2023-03-21 down Jefferies Buy → Equal-Weight $10
2022-11-04 up Raymond James Outperform → Strong Buy —
2022-03-07 main Cowen & Co. — → Outperform $14
2022-02-22 down Raymond James Strong Buy → Outperform $23
2020-09-15 init Jefferies — → Buy —
2020-09-10 init Lake Street — → Buy $22
2020-04-01 init Cowen & Co. — → Outperform $15
News
RSS: Latest PROF news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-06-17 Burtnyk (Mathieu) Senior Officer of Issuer — 11,618 $6.57 $76,376
2026-06-17 Dewan (Rashed Osman) Senior Officer of Issuer — 7,745 $6.57 $50,915
2026-06-17 Menawat (Arun Swarup Ph.D.) Director of Issuer — 70,350 $6.57 $462,480
2026-06-17 Tamberrino (Thomas Michael) Senior Officer of Issuer — 10,545 $6.57 $69,322
2026-03-20 Menawat (Arun Swarup Ph.D.) Director of Issuer — 20,000 $5.10 $101,920
2025-12-23 Menawat (Arun Swarup Ph.D.) Director of Issuer — 13,396 $7.46 $100,001
2025-12-23 Rosenthal (Arthur Lee) Director of Issuer — 13,900 $7.30 $101,470
2025-12-23 Tamberrino (Thomas Michael) Senior Officer of Issuer — 13,908 $7.19 $99,942
2025-11-24 Ellacott Brian R Director of Issuer — 719 $6.08 $4,373
2025-11-24 Lavoie (Cynthia Ph.D.) Director of Issuer — 719 $6.08 $4,373
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
16.10
+50.73%
10.68
+48.35%
7.20
+7.75%
6.68
Operating Revenue
16.10
+50.73%
10.68
+48.35%
7.20
+7.75%
6.68
Cost Of Revenue
4.71
+29.15%
3.64
+26.19%
2.89
-21.12%
3.66
Reconciled Cost Of Revenue
4.71
+29.15%
3.64
+26.19%
2.89
-21.12%
3.66
Gross Profit
11.39
+61.90%
7.04
+63.20%
4.31
+42.73%
3.02
Operating Expense
52.65
+31.29%
40.10
+21.65%
32.96
+1.04%
32.62
Research And Development
20.60
+21.40%
16.96
+17.62%
14.42
-1.81%
14.69
Selling General And Administration
32.05
+38.54%
23.13
+24.79%
18.54
+3.38%
17.93
Selling And Marketing Expense
—
—
9.45
+11.63%
8.47
General And Administrative Expense
—
—
9.17
-3.14%
9.46
Other Gand A
—
—
9.17
-3.14%
9.46
Total Expenses
57.35
+31.11%
43.74
+22.01%
35.85
-1.19%
36.28
Operating Income
-41.25
-24.78%
-33.06
-15.40%
-28.65
+3.21%
-29.60
Total Operating Income As Reported
-41.25
-24.78%
-33.06
-15.40%
-28.65
+10.82%
-32.13
EBITDA
-40.69
-26.67%
-32.13
-15.89%
-27.72
-4.20%
-26.60
Normalized EBITDA
-38.56
-7.31%
-35.93
-32.37%
-27.15
-0.90%
-26.91
Reconciled Depreciation
0.56
-40.17%
0.94
+0.75%
0.93
-42.08%
1.60
EBIT
-41.25
-24.78%
-33.06
-15.40%
-28.65
-1.57%
-28.21
Total Unusual Items
-2.13
-156.04%
3.81
+762.26%
-0.57
-291.03%
0.30
Total Unusual Items Excluding Goodwill
-2.13
-156.04%
3.81
+762.26%
-0.57
-291.03%
0.30
Special Income Charges
—
—
0.00
+100.00%
-2.52
Impairment Of Capital Assets
—
—
0.00
-100.00%
2.52
Restructuring And Mergern Acquisition
—
—
—
—
Net Income
-42.57
-53.04%
-27.82
+1.79%
-28.32
+1.21%
-28.67
Pretax Income
-42.32
-52.12%
-27.82
+2.22%
-28.45
-0.24%
-28.38
Net Non Operating Interest Income Expense
1.07
-25.49%
1.44
+85.29%
0.78
-15.67%
0.92
Interest Expense Non Operating
—
—
0.77
+342.53%
0.17
Net Interest Income
1.07
-25.49%
1.44
+85.29%
0.78
-15.67%
0.92
Interest Expense
—
—
0.77
+342.53%
0.17
Interest Income Non Operating
—
—
1.64
+104.48%
0.80
Interest Income
—
—
1.64
+104.48%
0.80
Other Income Expense
-2.13
-156.04%
3.81
+762.26%
-0.57
-291.03%
0.30
Gain On Sale Of Security
-2.13
-156.04%
3.81
+762.26%
-0.57
-120.35%
2.83
Tax Provision
0.25
+12700.00%
-0.00
+98.44%
-0.13
-144.60%
0.29
Tax Rate For Calcs
0.00
+208233.33%
0.00
-98.40%
0.00
-98.28%
0.00
Tax Effect Of Unusual Items
-0.32
-117018.88%
0.00
+110.58%
-0.00
-103.28%
0.08
Net Income Including Noncontrolling Interests
-42.57
-53.04%
-27.82
+1.79%
-28.32
+1.21%
-28.67
Net Income From Continuing Operation Net Minority Interest
-42.57
-53.04%
-27.82
+1.79%
-28.32
+1.21%
-28.67
Net Income From Continuing And Discontinued Operation
-42.57
-53.04%
-27.82
+1.79%
-28.32
+1.21%
-28.67
Net Income Continuous Operations
-42.57
-53.04%
-27.82
+1.79%
-28.32
+1.21%
-28.67
Normalized Income
-40.76
-28.88%
-31.62
-13.96%
-27.75
+3.95%
-28.89
Net Income Common Stockholders
-42.57
-53.04%
-27.82
+1.79%
-28.32
+1.21%
-28.67
Diluted EPS
-1.41
-25.89%
-1.12
+16.42%
-1.34
+2.90%
-1.38
Basic EPS
-1.41
-25.89%
-1.12
+16.42%
-1.34
+2.90%
-1.38
Basic Average Shares
30.23
+22.08%
24.77
+16.91%
21.18
+1.96%
20.77
Diluted Average Shares
30.23
+22.08%
24.77
+16.91%
21.18
+1.96%
20.77
Diluted NI Availto Com Stockholders
-42.57
-53.04%
-27.82
+1.79%
-28.32
+1.21%
-28.67
Rent Expense Supplemental
—
—
0.71
+44.15%
0.50
Total Other Finance Cost
-1.07
+25.49%
-1.44
-85.29%
-0.78
-167.24%
-0.29
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
77.47
+10.31%
70.23
+59.78%
43.96
-31.77%
64.42
Current Assets
76.09
+10.17%
69.06
+64.85%
41.90
-32.45%
62.02
Cash Cash Equivalents And Short Term Investments
59.72
+8.76%
54.91
+109.48%
26.21
-43.65%
46.52
Cash And Cash Equivalents
59.72
+8.76%
54.91
+109.48%
26.21
-43.65%
46.52
Cash Financial
59.72
+8.76%
54.91
+109.48%
26.21
-43.65%
46.52
Receivables
7.20
+2.20%
7.04
-3.33%
7.29
+14.88%
6.34
Accounts Receivable
7.20
+9.34%
6.58
-7.84%
7.14
+19.48%
5.98
Gross Accounts Receivable
—
6.58
-7.84%
7.14
+19.48%
5.98
Allowance For Doubtful Accounts Receivable
—
-0.16
+59.59%
-0.39
-173.43%
-0.14
Receivables Adjustments Allowances
—
-0.16
+59.59%
-0.39
-173.43%
-0.14
Other Receivables
—
0.31
+158.33%
0.12
+823.08%
0.01
Taxes Receivable
—
0.31
-25.60%
0.41
-16.19%
0.49
Inventory
8.24
+42.01%
5.80
-17.00%
6.99
-11.99%
7.94
Raw Materials
2.96
+50.61%
1.96
-16.46%
2.35
-5.62%
2.49
Finished Goods
5.28
+37.61%
3.84
-17.27%
4.64
-14.98%
5.46
Prepaid Assets
0.93
-29.00%
1.31
-7.04%
1.41
+15.06%
1.22
Total Non Current Assets
1.39
+18.56%
1.17
-43.25%
2.06
-14.06%
2.40
Net PPE
0.88
+7.43%
0.82
-47.71%
1.57
-8.56%
1.72
Gross PPE
2.47
-22.98%
3.21
-15.19%
3.79
-6.66%
4.06
Accumulated Depreciation
-1.59
+33.43%
-2.39
-7.85%
-2.22
+5.26%
-2.34
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
—
—
—
0.00
Other Properties
1.93
-27.65%
2.67
-17.73%
3.24
+76.78%
1.83
Leases
0.54
+0.00%
0.54
+0.00%
0.54
-75.60%
2.22
Goodwill And Other Intangible Assets
0.14
-47.13%
0.26
-46.73%
0.49
-27.94%
0.68
Goodwill
—
—
—
0.00
Other Intangible Assets
0.14
-47.13%
0.26
-46.73%
0.49
-27.94%
0.68
Non Current Accounts Receivable
0.30
—
—
—
Non Current Deferred Assets
0.07
-24.14%
0.09
0.00
—
Non Current Deferred Taxes Assets
0.07
-24.14%
0.09
0.00
—
Total Liabilities Net Minority Interest
11.04
+12.53%
9.81
-22.93%
12.73
+2.54%
12.42
Current Liabilities
6.08
-7.46%
6.57
+3.09%
6.37
+52.16%
4.18
Payables And Accrued Expenses
2.55
-18.42%
3.12
+66.99%
1.87
-19.82%
2.33
Payables
1.60
+21.64%
1.32
+52.25%
0.86
-62.89%
2.33
Accounts Payable
1.56
+18.68%
1.32
+52.25%
0.86
-57.45%
2.03
Current Accrued Expenses
0.94
-47.67%
1.80
+79.68%
1.00
—
Pensionand Other Post Retirement Benefit Plans Current
2.35
+232.44%
0.71
-6.12%
0.75
—
Total Tax Payable
0.04
0.00
0.00
-100.00%
0.30
Income Tax Payable
0.04
0.00
0.00
-100.00%
0.30
Current Debt And Capital Lease Obligation
0.21
-89.32%
1.99
-15.62%
2.36
+210.10%
0.76
Current Debt
—
1.74
-17.44%
2.10
+302.29%
0.52
Other Current Borrowings
—
1.74
-17.44%
2.10
+302.29%
0.52
Current Capital Lease Obligation
0.21
-17.12%
0.26
-0.77%
0.26
+8.37%
0.24
Current Deferred Liabilities
0.45
+6.21%
0.42
-41.89%
0.72
+53.08%
0.47
Current Deferred Revenue
0.45
+6.21%
0.42
-41.89%
0.72
+53.08%
0.47
Other Current Liabilities
0.52
+61.23%
0.33
-50.98%
0.66
+17.76%
0.56
Total Non Current Liabilities Net Minority Interest
4.97
+52.94%
3.25
-48.98%
6.36
-22.69%
8.23
Long Term Debt And Capital Lease Obligation
4.50
+43.88%
3.13
-43.19%
5.50
-26.30%
7.47
Long Term Debt
4.50
+53.86%
2.92
-41.52%
5.00
-24.82%
6.65
Long Term Capital Lease Obligation
0.00
-100.00%
0.20
-59.72%
0.50
-38.31%
0.82
Non Current Deferred Liabilities
0.39
+691.84%
0.05
-93.77%
0.79
+3.01%
0.76
Non Current Deferred Revenue
0.39
+691.84%
0.05
-93.27%
0.73
-4.71%
0.76
Non Current Deferred Taxes Liabilities
—
0.00
-100.00%
0.06
0.00
Other Non Current Liabilities
0.08
+11.27%
0.07
-2.74%
0.07
—
Stockholders Equity
66.43
+9.95%
60.42
+93.51%
31.22
-39.96%
52.00
Common Stock Equity
66.43
+9.95%
60.42
+93.51%
31.22
-39.96%
52.00
Capital Stock
323.84
+15.02%
281.55
+26.71%
222.21
+7.96%
205.82
Common Stock
323.84
+15.02%
281.55
+26.71%
222.21
+7.96%
205.82
Share Issued
36.29
+20.82%
30.04
+40.57%
21.37
+2.35%
20.88
Ordinary Shares Number
36.29
+20.82%
30.04
+40.57%
21.37
+2.35%
20.88
Additional Paid In Capital
25.31
+18.84%
21.30
+2.35%
20.81
+11.25%
18.70
Retained Earnings
-287.74
-17.36%
-245.17
-12.80%
-217.35
-14.78%
-189.36
Gains Losses Not Affecting Retained Earnings
5.03
+83.26%
2.74
-50.73%
5.57
-66.95%
16.84
Other Equity Adjustments
5.03
+83.26%
2.74
-50.73%
5.57
-66.95%
16.84
Total Equity Gross Minority Interest
66.43
+9.95%
60.42
+93.51%
31.22
-39.96%
52.00
Total Capitalization
70.93
+11.98%
63.35
+74.87%
36.22
-38.24%
58.66
Working Capital
70.01
+12.02%
62.50
+75.92%
35.53
-38.57%
57.84
Invested Capital
70.93
+8.99%
65.08
+69.81%
38.33
-35.23%
59.18
Total Debt
4.71
-7.99%
5.12
-34.91%
7.87
-4.41%
8.23
Capital Lease Obligations
0.21
-53.70%
0.46
-39.71%
0.76
-27.75%
1.06
Net Tangible Assets
66.30
+10.20%
60.16
+95.75%
30.73
-40.12%
51.32
Tangible Book Value
66.30
+10.20%
60.16
+95.75%
30.73
-40.12%
51.32
Current Provisions
—
—
—
0.06
Inventories Adjustments Allowances
—
—
-0.01
-60.00%
-0.01
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-38.21
-62.91%
-23.45
-3.73%
-22.61
+12.37%
-25.80
Cash Flow From Continuing Operating Activities
-38.21
-62.91%
-23.45
-3.73%
-22.61
+12.37%
-25.80
Net Income From Continuing Operations
-42.57
-53.04%
-27.82
+1.79%
-28.32
+1.21%
-28.67
Depreciation Amortization Depletion
0.56
-40.17%
0.94
+0.75%
0.93
-42.08%
1.60
Depreciation
0.37
-47.24%
0.71
-2.75%
0.73
-19.22%
0.90
Amortization Cash Flow
0.19
-18.34%
0.23
+13.37%
0.20
-71.31%
0.70
Depreciation And Amortization
0.56
-40.17%
0.94
+0.75%
0.93
-42.08%
1.60
Amortization Of Intangibles
0.19
-18.34%
0.23
+13.37%
0.20
-71.31%
0.70
Other Non Cash Items
0.03
-89.80%
0.26
-69.20%
0.83
+679.02%
-0.14
Stock Based Compensation
5.49
+112.71%
2.58
-24.47%
3.42
-19.37%
4.24
Asset Impairment Charge
—
—
0.00
-100.00%
2.52
Operating Gains Losses
—
—
0.23
-15.64%
0.28
Gain Loss On Investment Securities
—
—
0.23
-15.64%
0.28
Change In Working Capital
-1.71
-389.85%
0.59
+9.44%
0.54
+109.59%
-5.63
Change In Receivables
-0.17
-192.47%
0.19
+119.46%
-0.96
+32.87%
-1.42
Changes In Account Receivables
—
—
—
—
Change In Inventory
-2.82
-530.18%
0.66
+85.84%
0.35
+118.94%
-1.86
Change In Prepaid Assets
0.46
+1396.77%
0.03
+119.62%
-0.16
-0.64%
-0.16
Change In Payables And Accrued Expense
0.42
-48.47%
0.81
-22.75%
1.05
+513.73%
-0.26
Change In Payable
0.42
-48.47%
0.81
-22.75%
1.05
+513.73%
-0.26
Change In Account Payable
0.38
-53.62%
0.81
-39.81%
1.35
+339.22%
-0.57
Change In Other Working Capital
0.40
+136.19%
-1.10
-545.93%
0.25
+112.75%
-1.93
Investing Cash Flow
-0.24
0.00
—
0.00
Cash Flow From Continuing Investing Activities
-0.24
0.00
—
0.00
Net PPE Purchase And Sale
-0.18
0.00
—
0.00
Purchase Of PPE
-0.18
0.00
—
0.00
Capital Expenditure
-0.24
—
—
—
Net Intangibles Purchase And Sale
-0.07
0.00
—
0.00
Purchase Of Intangibles
-0.07
0.00
—
0.00
Financing Cash Flow
41.14
-24.79%
54.70
+3014.81%
1.76
-75.02%
7.03
Cash Flow From Continuing Financing Activities
41.14
-24.79%
54.70
+3014.81%
1.76
-75.02%
7.03
Net Issuance Payments Of Debt
-0.29
+88.67%
-2.56
-180.70%
-0.91
-113.18%
6.92
Issuance Of Debt
—
—
0.00
-100.00%
7.27
Repayment Of Debt
-0.29
+88.67%
-2.56
-180.70%
-0.91
-156.18%
-0.36
Long Term Debt Issuance
—
—
0.00
-100.00%
7.27
Long Term Debt Payments
-0.29
+88.67%
-2.56
-180.70%
-0.91
-156.18%
-0.36
Net Long Term Debt Issuance
-0.29
+88.67%
-2.56
-180.70%
-0.91
-113.18%
6.92
Net Common Stock Issuance
42.44
-31.67%
62.11
0.00
—
Proceeds From Stock Option Exercised
0.01
-82.22%
0.04
-98.31%
2.67
+914.45%
0.26
Net Other Financing Charges
-1.02
+79.24%
-4.89
—
-0.15
Changes In Cash
2.69
-91.39%
31.24
+249.82%
-20.85
-11.10%
-18.77
Effect Of Exchange Rate Changes
2.12
+183.41%
-2.54
-563.39%
0.55
+129.42%
-1.87
Beginning Cash Position
54.91
+109.48%
26.21
-43.65%
46.52
-30.73%
67.15
End Cash Position
59.72
+8.76%
54.91
+109.48%
26.21
-43.65%
46.52
Free Cash Flow
-38.45
-63.94%
-23.45
-3.73%
-22.61
+12.37%
-25.80
Interest Paid Supplemental Data
—
—
0.67
+1455.81%
0.04
Income Tax Paid Supplemental Data
—
—
0.16
+190.91%
0.06
Change In Income Tax Payable
0.04
0.00
+100.00%
-0.30
-196.14%
0.31
Change In Tax Payable
0.04
0.00
+100.00%
-0.30
-196.14%
0.31
Common Stock Issuance
42.44
-31.67%
62.11
0.00
—
Issuance Of Capital Stock
42.44
-31.67%
62.11
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category